Sex hormone-binding globulin and risk of hyperglycemia in patients with androgenetic alopecia

Journal of the American Academy of Dermatology

Volumn 65, Issue 1, 2011, Pages 48-53

  Arias Santiago, Salvador ^a   Gutiérrez Salmerón, María Teresa ^a   Buendía Eisman, Agustín ^a   Girón Prieto, María Sierra ^a   Naranjo Sintes, Ramón ^a  

^a HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

Author keywords

abdominal obesity; androgenetic alopecia; HOMA IR index; hyperglycemia; insulin levels; SHBG; testosterone; type 2 diabetes

Indexed keywords

GLUCOSE; SEX HORMONE BINDING GLOBULIN;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; MALE TYPE ALOPECIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR;

ADULT; AGE DISTRIBUTION; ALOPECIA; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERGLYCEMIA; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; SEX DISTRIBUTION; SEX HORMONE-BINDING GLOBULIN;

EID: 79958862541     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2010.05.002     Document Type: Article

References (20)

1. Ding EL, Song Y, Manson JE, Hunter DJ, Lee CC, Rifai N, et al. Sex hormone-binding globulin and risk of type 2 diabetes in women and men. N Engl J Med 2009;361:1152-63.
2. Hirsso P, Laakso M, Matilainen V, Hiltunen L, Rajala U, Jokelainen J, et al. Association of insulin resistance linked diseases and hair loss in elderly men. Finnish population-based study. Cent Eur J Public Health 2006;14:78-81. (Pubitemid 44014533)
3. Lescko SM, Rosenberg L, Shapiro S. A case-control study of baldness in relation to myocardial infarction in men. JAMA 1993;269:998-1003. (Pubitemid 23066636)
4. Lotufo PA, Chae CU, Ajani UA, Hennekens CH, Manson JE. Male pattern baldness and coronary heart disease: the Physiciańs Health Study. Arch Intern Med 2000;160:165-77.
5. Herrera CR, D'Agostino RB, Gerstmann BB, Bosco LA, Belanger AJ. Baldness and coronary heart disease rates in men from Framingham study. Am J Epidemiol 1996;142:828-33.
6. Ford ES, Freedman DS, Byers T. Baldness and ischemic heart disease in a national sample of men. Am J Epidemiol 1996;143:651-7. (Pubitemid 26108232)
7. Matilainen VA, Mäkinen PK, Keinännen-Kiukaanniemi SM. Early onset of androgenetic alopecia associated with early severe coronary heart disease: a population-based, case control study. J Cardiovasc Risk 2001;8:147-51. (Pubitemid 32619889)
8. Arias-Santiago S, Gutiérrez-Salmerón MT, Castellote-Caballero L, Buendía-Eisman A, Naranjo-Sintes R. Androgenetic alopecia and cardiovascular risk factors in men and woman: A comparative study. J Am Acad Dermatol 2010;63:420-9.
9. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999;84:3666-72. (Pubitemid 30645223)
10. Adult Treatment Panel III. Executive summary on the third report of the national cholesterol education program (NECP): expert panel on detection, evaluation and treatment of high blood cholesterol in adults. JAMA 2001;285:2486-97.
11. Golden SH, Dobs AS, Vaidya D, Szklo M, Gapstur S, Kopp P, et al. Endogenous sex hormones and glucose tolerance status in postmenopausal women. J Clin Endocrinol Metab 2007;92:1289-95. (Pubitemid 46556400)
12. Matilainen V, Koskela P, Keinänen-Kiukaanniemi S. Early androgenetic alopecia as a marker of insulin resistance. Lancet 2000;356:1165-6.
13. Ekmekci TR, Ucak S, Basat O, Koslu A, Altuntas Y. The presence of insulin resistance and comparison of various insulin sensitivity indices in women with androgenetic alopecia. Eur J Dermatol 2007;17:21-5. (Pubitemid 46383215)
14. González-González JG, Mancillas-Adame LG, Fernández-Reyes M, Gómez-Flores M, Lavalle-González FJ, Ocampo-Candiani J, et al. Androgenetic alopecia and insulin resistance in young men. Clin Endocrinol (Oxf) 2009;71:494-9.
15. Hirsso P, Rajala U, Hiltunen L, Jokelainen J, Keinänen-Kiukaanniemi S, Näyhä S. Obesity and low-grade Inflammation among young Finnish men with early-onset alopecia. Dermatology 2007;214:125-9. (Pubitemid 46377236)
16. Catalano MG, Frairia R, Boccuzzi G, Fortunati N. Sex hormone-binding globulin antagonizes the anti-apoptotic effect of estradiol in breast cancer cells. Mol Cell Endocrinol 2005;230:31-7. (Pubitemid 40138968)
17. Hernández-Mijares A, García-Malpartida K, Solá-Izquierdo E, Bañuls C, Rocha M, Gómez-Martínez MJ, et al. Testosterone levels in males with type 2 diabetes and their relationship with cardiovascular risk factors and cardiovascular disease. J Sex Med 2010;7:1954-64. Epub 2010 Feb 25.
18. Lakshman KM, Bhasin S, Araujo AB. Sex hormone-binding globulin as an independent predictor of incident type 2 diabetes mellitus in men. J Gerontol A Biol Sci Med Sci 2010;65:503-9.
19. Arias-Santiago S, Gutierrez-Salmerón MT, Castellote-Caballero L, Naranjo-Sintes R. Elevated aldosterone levels in patients with androgenetic alopecia. Br J Dermatol 2009;161:1196-8.
20. Arias-Santiago S, Gutiérrez-Salmeron MT, Buendía-Eisman A, Girón-Pireto MS, Naranjo-Sintes R, et al. Hypertension and aldosterone levels in women with early-onset androgenetic alopecia. Br J Dermatol 2010;162:786-9. Epub 2009 Nov 10.